Titre:
  • Pregnancy outcomes in inflammatory bowel disease patients treated with vedolizumab, anti-TNF or conventional therapy: results of the European CONCEIVE study.
Auteur:Moens, Annick; van der Woude, Janneke CJ; Julsgaard, Mette; Humblet, Evelien; Sheridan, Juliette; Baumgart, Daniel; Gilletta De Saint-Joseph, Cyrielle; Nancey, Stéphane; Rahier, Jean François; Bossuyt, Peter; Cremer, Anneline; Dewit, Sophie; Eriksson, C; Hoentjen, Frank; Krause, Thomas; Louis, Edouard; Macken, Elisabeth; Milenkovic, Zoran; Nijs, Jochen; Posen, Annelies; Van Hootegem, Anneleen; Van Moerkercke, W.; Vermeire, Séverine; Bar-Gil Shitrit, Ariella; Ferrante, Marc
Informations sur la publication:Alimentary pharmacology & therapeutics, 51, 1, page (129-138)
Statut de publication:Publié, 2020-01-01
Sujet CREF:Sciences bio-médicales et agricoles
Langue:Anglais
Identificateurs:urn:issn:0269-2813
info:doi/10.1111/apt.15539
info:pmid/31692017